Get started
Author

Jordina Rovira

Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy
2014 · Jordina Rovira, Alexandra Valera, et al. · Annals of Hematology · 119
PDF
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
2020 · Alfredo Rivas-Delgado, Ferran Nadeu, et al. · Clinical Cancer Research · 97
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era
2018 · Alfredo Rivas‐Delgado, Laura Magnano, et al. · British Journal of Haematology · 88
Validation of the NCCN ‐ IPI for diffuse large B‐cell lymphoma ( DLBCL ): the addition of β2‐microglobulin yields a more accurate GELTAMO ‐ IPI
2017 · Carlos Montalbán, Antonio Díaz‐López, et al. · British Journal of Haematology · 82
PDF
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma
2017 · Blanca Gonzalez-Farre, Daniel Martinez, et al. · Modern Pathology · 77
PDF
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome
2016 · Jordina Rovira, Kennosuke Karube, et al. · Clinical Cancer Research · 73
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
2013 · Silvia Fuertes, Xavier Setoain, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 56
High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma
2017 · Ivan Dlouhy, Xavier Filella, et al. · Leukemia Research · 55
Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: Report of 2 Cases and Review of Literature
2013 · Jordina Rovira, Joan Cid, et al. · Transfusion Medicine Reviews · 41
In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications
2014 · Blanca Gonzalez-Farre, Jordina Rovira, et al. · Modern Pathology · 27
PDF
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy
2016 · Ivan Dlouhy, Miguel Á. Torrente, et al. · Annals of Hematology · 25
Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome
2022 · Ana Muntañola, Pablo Mozas, et al. · British Journal of Haematology · 16
Revised International Prognostic Index and genetic alterations are associated with early failure to R‐CHOP in patients with diffuse large B‐cell lymphoma
2021 · Ivan Dlouhy, Kennosuke Karube, et al. · British Journal of Haematology · 15
T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome
2016 · Laura Magnano, Antonio Martínez, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
2025 · Leyre Bento, Antonio Gutiérrez, et al. · Blood Advances · 5
Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era
2019 · Antonio Gutierrez, Leyre Bento, et al. · European Journal Of Haematology · 3
Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era
2017 · Antonio Gutierrez, Leyre Bento, et al. · Blood · 1
Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets
2016 · Ivan Dlouhy, Kennosuke Karube, et al. · Blood · 1
Different Clinical Features but Not Outcome in SLL Patients Compared to CLL,
2011 · Alejandra Martinez-Trillos, Eva Gine, et al. · Blood · 1
Primary Mediastinal B Cell Lymphoma (PMBCL): A Multicentric Observational Study of Spanish Lymphoma Group Geltamo
2024 · Almudena Cabero Martínez, Ana García Bacelar, et al. · Blood
PDF
Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study
2024 · Leyre Bento De Miguel, Mariana Bastos-Oreiro, et al. · Blood
Autologous Stem Cell Transplantation Remains a Curative Option As Second Line Treatment for Patients with Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geth-TC/Geltamo Study
2023 · Leyre Bento, Antonio Gutiérrez, et al. · Blood
PDF
Supplemental material from MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome
2023 · Jordina Rovira, Kennosuke Karube, et al.
Supplemental Material from Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
2023 · Alfredo Rivas-Delgado, Ferran Nadeu, et al.
Supplementary tables from Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
2023 · Alfredo Rivas-Delgado, Ferran Nadeu, et al.
Works count: 37
Citation count: 789
H-index: 13
I10-index: 13
Year
Topic
Type